News Scotland says yes to Truvada as PrEP The Scottish Medicines Consortium has approved the use of Gilead’s Truvada for use in preventing new HIV infections, so called pre-exposure prophylaxis (PrEP).
News NHS England confirms HIV prevention funding - but only via c... Large trial of HIV PrEP could lead to national programme
News Gilead donates Truvada to HIV trial patients PROUD trial patients can continue treatment for six months.
News EU approves Gilead's Truvada for HIV prevention But there are funding problems in UK, Australia and Canada.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.